What does the evidence say about Ginger Sleep Quality Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Ginger Sleep Quality Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Objective To systematically review and meta-analyze evidence from animal studies and human randomized controlled trials assessing the efficacy of ginger-based formulations in allergic rhinitis. [Inpan R (2026); evidence level 1] - Risk of bias was assessed using the SYRCLE tool for animal studies and RoB2 for human studies. [Inpan R (2026); evidence level 1] - In rodents, ginger-based formulations significantly reduced nasal rubbing (SMD = -1.99; 95%CI, -3.15 to -0.83), sneezing (SMD = -1.99; 95%CI, -2.78 to -1.20), and biomarkers (IL-4, IL-5, and OVA-specific IgE). [Inpan R (2026); evidence level 1] - Background Allergic rhinitis is a chronic non-communicable disease that adversely affects respiratory health and quality of life. [Inpan R (2026); evidence level 1] - The meta-analysis showed that the response rate in the experimental group was higher than in the control group (p Conclusion The current evidence suggests that CHM can enhance the efficacy of AR treatment, improve patients' quality of life, and result in a lower rate of adverse reactions. [Zhu H (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.